Literature DB >> 11222715

Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice.

A K Raney1, C M Eggers, E F Kline, L G Guidotti, M Pontoglio, M Yaniv, A McLachlan.   

Abstract

The role of hepatocyte nuclear factor 1alpha (HNF1 alpha) in the regulation of hepatitis B virus (HBV) transcription and replication in vivo was investigated using a HNF1 alpha-null HBV transgenic mouse model. HBV transcription was not measurably affected by the absence of the HNF1 alpha transcription factor. However, intracellular viral replication intermediates were increased two- to fourfold in mice lacking functional HNF1 alpha protein. The increase in encapsidated cytoplasmic replication intermediates in HNF1 alpha-null HBV transgenic mice was associated with the appearance of nonencapsidated nuclear covalently closed circular (CCC) viral genomic DNA. Viral CCC DNA was not readily detected in HNF1 alpha-expressing HBV transgenic mice. This indicates the synthesis of nuclear HBV CCC DNA, the proposed viral transcriptional template found in natural infection, is regulated either by subtle alterations in the levels of viral transcripts or by changes in the physiological state of the hepatocyte in this in vivo model of HBV replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222715      PMCID: PMC115916          DOI: 10.1128/JVI.75.6.2900-2911.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Transcriptional control of hepadnavirus gene expression.

Authors:  H Schaller; M Fischer
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

2.  Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript.

Authors:  J H Ou; H Bao; C Shih; S M Tahara
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter.

Authors:  D X Zhou; T S Yen
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

Review 4.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Mapping a region of the large envelope protein required for hepatitis B virion maturation.

Authors:  V Bruss; R Thomssen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1.

Authors:  A K Raney; A J Easton; D R Milich; A McLachlan
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Characterization of the minimal elements of the hepatitis B virus large surface antigen promoter.

Authors:  A K Raney; A J Easton; A McLachlan
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

10.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  52 in total

Review 1.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

Review 2.  Hepatitis B virus replication.

Authors:  Juergen Beck; Michael Nassal
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 3.  Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.

Authors:  Abdullah Ely; Buhle Moyo; Patrick Arbuthnot
Journal:  Mol Ther       Date:  2016-02-26       Impact factor: 11.454

Review 4.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.

Authors:  Aimee L Anderson; Krista E Banks; Marco Pontoglio; Moshe Yaniv; Alan McLachlan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.

Authors:  Zhihua Qi; Gaiyun Li; Hao Hu; Chunhui Yang; Xiaoming Zhang; Qibin Leng; Youhua Xie; Demin Yu; Xinxin Zhang; Yueqiu Gao; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.

Authors:  Phillip Moheno; John Morrey; Dietmar Fuchs
Journal:  J Transl Med       Date:  2010-03-31       Impact factor: 5.531

Review 8.  Core promoter: a critical region where the hepatitis B virus makes decisions.

Authors:  Jorge Quarleri
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.

Authors:  Wenhui He; Zhiliang Cao; Fengfeng Mao; Bijie Ren; Yunfei Li; Dan Li; Huiyu Li; Bo Peng; Huan Yan; Yonghe Qi; Yinyan Sun; Fengchao Wang; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Efficacy of cationic lipid-DNA complexes (CLDC) on hepatitis B virus in transgenic mice.

Authors:  John D Morrey; Neil E Motter; Brandon Taro; Marla Lay; Jeffery Fairman
Journal:  Antiviral Res       Date:  2008-02-25       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.